This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Quetiapine Augmentation of Sertraline in Obsessive-Compulsive Disorder

Giorgio Francobandiera

Published: November 1, 2002

Article Abstract

Letter to the Editor

Sir: Patients affected by obsessive-compulsive disorder (OCD) often do not respond to specific pharmacologic treatments such as clomipramine and selective serotonin reuptake inhibitors (SSRIs) (approximately 40%-60% of cases). In up to 65% of this large subgroup of treatment-resistant patients, the addition of traditional neuroleptics appears to be useful, especially if comorbid chronic tics or schizotypal personality disorder is present. However, the long-term administration of traditional antipsychotics often leads to undesirable side effects such as tardive dyskinesia.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Depression (MDD)


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...